Hikita E - Search Results

1

Delayed immune-related adverse events in long-responders of immunotherapy: a single-center experience.

Kitano M, Honda T, Hikita E, Masuo M, Miyazaki Y, Kobayashi M. Kitano M, et al. Among authors: hikita e. Asia Pac J Clin Oncol. 2024 Apr 12. doi: 10.1111/ajco.14059. Online ahead of print. Asia Pac J Clin Oncol. 2024. PMID: 38608154

2

Development of a simple high-performance liquid chromatography-ultraviolet method for sotorasib quantification in human plasma: Implications for therapeutic drug monitoring.

Hikita E, Gando Y, Chubachi H, Shirota M, Kushiyama A, Yasu T. Hikita E, et al. Drug Discov Ther. 2023 Sep 15;17(4):289-293. doi: 10.5582/ddt.2023.01043. Epub 2023 Aug 19. Drug Discov Ther. 2023. PMID: 37599084 Free article.

3

Impact of tablet crushing on the dissolution of venetoclax.

Yasu T, Hikita E, Gando Y, Odate M, Inoue M, Shirota M. Yasu T, et al. Among authors: hikita e. Ann Hematol. 2023 Jan;102(1):219-220. doi: 10.1007/s00277-022-05014-3. Epub 2022 Nov 4. Ann Hematol. 2023. PMID: 36333488 No abstract available.

4

Atovaquone-induced thrombocytopenia: A case report.

Hikita E, Yasu T, Chiyounabayashi S, Shirota M. Hikita E, et al. Int J Clin Pharmacol Ther. 2023 Feb;61(2):90-92. doi: 10.5414/CP204258. Int J Clin Pharmacol Ther. 2023. PMID: 36331013 No abstract available.

5

Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD Patients.

Kamada Y, Takahashi H, Ogawa Y, Hyogo H, Nakamura K, Yada T, Asada N, Bando T, Sawano H, Hatanaka M, Tosa T, Ando M, Hikita E, Yoshida K, Koseki M, Sumida Y, Maeda K, Fujii M, Aishima S, Hayakawa M, Nakajima A; Japan Study Group of NAFLD (JSG-NAFLD). Kamada Y, et al. Among authors: hikita e. Nutrients. 2022 Aug 23;14(17):3453. doi: 10.3390/nu14173453. Nutrients. 2022. PMID: 36079715 Free PMC article.

6

Interaction Between Levodopa and Banana in a Patient With Parkinson's Disease.

Hotozuka S, Yasu T, Hikita E, Shirota M. Hotozuka S, et al. Among authors: hikita e. Am J Ther. 2022 Jul 1;29(4):465-467. doi: 10.1097/MJT.0000000000001420. Am J Ther. 2022. PMID: 35802918 No abstract available.

7

[Evaluation of Usefulness of the Tools for Collaboration between Hospital and Community Pharmacists in the Provision of Outpatient Cancer Chemotherapy].

Hikita E, Urayama Y, Kuroki A, Yasu T, Shirota M. Hikita E, et al. Gan To Kagaku Ryoho. 2022 Feb;49(2):167-171. Gan To Kagaku Ryoho. 2022. PMID: 35249052 Japanese.

8

Elevated Prothrombin Time and International Normalized Ratio Caused by Drug-Drug Interactions Between Warfarin and Pranlukast.

Tamai E, Yasu T, Hikita E, Shirota M. Tamai E, et al. Among authors: hikita e. Am J Ther. 2023 May 1;30(3):e302-e303. doi: 10.1097/MJT.0000000000001394. Am J Ther. 2023. PMID: 34050048 No abstract available.

9

Efficacy of Naldemedine in the Management of Constipation in a Patient with Severe COVID-19 Receiving Mechanical Ventilation.

Hikita E, Hashimoto M, Yasu T, Shirota M, Nakamura K. Hikita E, et al. J Palliat Med. 2021 May;24(5):651-652. doi: 10.1089/jpm.2021.0028. Epub 2021 Feb 5. J Palliat Med. 2021. PMID: 33544649 No abstract available.

10

Effects of inorganic and organic arsenic compounds on growth and apoptosis of human T-lymphoblastoid leukemia cells.

Hikita E, Arai M, Tanaka S, Onda K, Utsumi H, Yuan B, Toyoda H, Hirano T. Hikita E, et al. Anticancer Res. 2011 Dec;31(12):4169-78. Anticancer Res. 2011. PMID: 22199276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page